SCHEMBL28292787

SCHEMBL28292787

O=C(OBr)c1cc(F)cc(F)c1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CES2 O00748 3/20 0.54
CES1 P23141 3/20 0.54
HCAR1 Q9BXC0 1/20 0.40
SLC6A3 Q01959 1/20 0.36
CA12 O43570 1/20 0.36
CA1 P00915 1/20 0.36
CA9 Q16790 1/20 0.36
MEN1 O00255 2/20 0.36
KMT2A Q03164 2/20 0.36
NPC1 O15118 2/20 0.35
RAB9A P51151 2/20 0.35
HCAR2 Q8TDS4 1/20 0.34
PARP1 P09874 1/20 0.34
LMNA P02545 1/20 0.34
KDM4E B2RXH2 1/20 0.33
ESR1 P03372 1/20 0.33
ESR2 Q92731 1/20 0.33
TTR P02766 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
HDAC3 O15379 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30954388 0.80 CES2 (0.59) CES2CES1HCAR1SLC6A3CA12
SCHEMBL2410692 0.79 CES2 (0.61) CES2CES1MEN1KMT2ANPC1
SCHEMBL6972626 0.78 CES2 (0.56) CES2CES1HCAR1SLC6A3CA12
SCHEMBL28270453 0.76 CES2 (0.54) CES2CES1CA1MEN1KMT2A
SCHEMBL10228062 0.76 CES2 (0.54) CES2CES1HCAR1SLC6A3CA12
SCHEMBL521670 0.76 CA1 (0.58) CES2CES1SLC6A3CA12CA1
SCHEMBL28803913 0.73 CA12 (0.60) HCAR1CA12CA1CA9LMNA
SCHEMBL29062216 0.72 CES2 (0.62) CES2CES1HCAR1SLC6A3CA12
SCHEMBL27964419 0.71 TPMT (0.52) HCAR1CA12CA1CA9MEN1
SCHEMBL1401499 0.71 CA1 (0.58) CES2CES1CA12CA1CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109661392-A For treating the mitochondrial inhibitors of proliferative disorder 巴斯利尔药物国际股份公司 2019-04-19 CN disclosed